The Heart Outcomes Prevention Evaluation (HOPE) study was a landmark study employing the angiotensin-converting enzyme (ACE) inhibitor ramipril in a patient population predestined for vascular events.

The researchers described the extreme “pre-morbid” vulnerability of older hostages along with the additional data on their ...

Angiotensin-converting enzyme inhibitor drugs such as lisinopril, captopril, enalapril, ramipril may increase the response to angiotensin II. • Angiotensin II receptor blocker drugs such as ...

but likely stomach and duodenum due to rapid absorption h Monitor for decreased efficacy Ramipril Unknown; decreased absorption documented in patients with steatorrhea and malabsorption i Consider ...